Oncostatin M: a pleiotropic cytokine in the central nervous system

被引:76
作者
Chen, SH
Benveniste, EN
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, MCLM 386, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, MCLM 395, Birmingham, AL 35294 USA
关键词
oncostatin M; signal transduction; central nervous system; brain tumors; glial cells;
D O I
10.1016/j.cytogfr.2004.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncostatin M (OSM), a member of the interleukin-6 (IL-6) cytokine family, has yet to be well studied, especially in the context of the central nervous system (CNS). The biological functions of OSM are complex and variable, depending on the cellular microenvironment. Inflammatory responses and tumor development are among two of the major events that OSM is involved in. Although OSM levels remain low in the normal CNS. elevated expression occurs in pathological conditions. Therefore, it is crucial to understand the regulation of OSM to control its expression and/or its effects. Accumulating data demonstrate that OSM binds to specific receptor complexes, then activates two major signaling pathways: Janus Kinase-Signal Transducers and Activators of Transcription (JAK-STAT) and Mitogen-Activated Protein Kinase (MAPK), to regulate downstream events. In this review, we focus on the biological functions of OSM, the signaling pathways of OSM in the CNS. and OSM involvement in CNS diseases. (C) 2004, Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 391
页数:13
相关论文
共 120 条
  • [71] Dual oncostatin M (OSM) receptors - Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
    Mosley, B
    DeImus, C
    Friend, D
    Boiani, N
    Thoma, B
    Park, LS
    Cosman, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) : 32635 - 32643
  • [72] Muir E, 1998, GLIA, V23, P24, DOI 10.1002/(SICI)1098-1136(199805)23:1<24::AID-GLIA3>3.0.CO
  • [73] 2-4
  • [74] Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases
    Nagashima, G
    Suzuki, R
    Asai, J
    Fujimoto, T
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (02) : 125 - 131
  • [75] Nakashima K, 1999, J NEUROSCI, V19, P5429
  • [76] Isolation and characterization of the human gp130 promoter - Regulation by STATS
    OBrien, CA
    Manolagas, SC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) : 15003 - 15010
  • [77] Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO
  • [78] 2-7
  • [79] Expression and distribution of vascular endothelial growth factor protein in human brain tumors
    Pietsch, T
    Valter, MM
    Wolf, HK
    vonDeimling, A
    Huang, HJS
    Cavenee, WK
    Wiestler, OD
    [J]. ACTA NEUROPATHOLOGICA, 1997, 93 (02) : 109 - 117
  • [80] RADKA SF, 1993, J IMMUNOL, V150, P5195